This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:
—Knowing that it has been the policy of The Journal to prevent misconceptions and referring to the recent article by Doyle and Daniels (Symptomatic Treatment for Narcolepsy, The Journal, April 25, p. 1370), in which the value of ephedrine for the relief of this syndrome is established on the basis of six observations, it is only fair to point out that a previous communication on this subject has been overlooked. In discussing a presentation by Professor Pelnar, "Narcolepsie avec cataplexie" at the Société de neurologie of Prague, June 18, 1930 (Rev. neurol. 37:427 [Oct.] 1930), Janota and Skala reported three cases of narcolepsy most favorably influenced by ephedrine and stressed the fact that the drug did not seem to possess the same inhibitory effect on the cataplexic component of the syndrome. It was their belief that ephedrine had not been employed, prior to that time, in
Archambault L. "SYMPTOMATIC TREATMENT FOR NARCOLEPSY". JAMA. 1931;96(23):1975. doi:10.1001/jama.1931.02720490055030
Customize your JAMA Network experience by selecting one or more topics from the list below.